Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The aim of study was to assess the efficiency and safety of oral IL-1βinhibitor in
combination with urate lowering therapy on joint pain intensity,urate control, global
assessments of disease activity, self-monitored gouty acute flare times, inflammatory markers
and symptoms improving related life quantity in gouty patients.